What dose of dobutamine in a 2-year-old child would produce a vasopressor effect?

Dobutamine Does Not Produce Vasopressor Effects in Children

Dobutamine is not a vasopressor and does not produce vasoconstrictive effects at standard therapeutic doses in children. In fact, dobutamine typically maintains or slightly decreases systemic vascular resistance (SVR) while increasing cardiac output through its beta-adrenergic effects 1.

Mechanism and Hemodynamic Profile

Dobutamine is a beta-1 selective inotrope that primarily stimulates cardiac contractility while producing "comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects" 1. The drug's pharmacology is fundamentally different from true vasopressors:

• Beta-adrenergic stimulation predominates: Dobutamine acts on beta-1 receptors in the heart to increase contractility
• Vasodilation, not vasoconstriction: The drug typically decreases SVR rather than increasing it 1
• Occasional minimal vasoconstriction: While the FDA label notes that "occasionally, minimum vasoconstriction has been observed," this is rare and not the primary effect 1

Dosing in Pediatric Patients

The standard therapeutic range for dobutamine in children is 2-20 μg/kg/min 2, 1. Even at the upper end of this range and beyond, the drug does not transition to vasopressor activity:

• Starting dose: 0.5-1.0 μg/kg/min, titrated upward 1
• Typical therapeutic range: 2-20 μg/kg/min 2, 1
• Maximum reported doses: Up to 40 μg/kg/min have been used in rare circumstances 1
• Pediatric-specific data: Studies in children aged 1 month to 17 years using doses of 2.5-10 μg/kg/min showed increased cardiac output (30%), blood pressure (17%), and heart rate (7%) without vasoconstrictive effects 3

Clinical Context for a 2-Year-Old

For low cardiac output states with adequate or elevated SVR, dobutamine is the appropriate first-line inotrope 2. The 2007 American College of Critical Care Medicine guidelines specifically recommend dobutamine for this hemodynamic profile in pediatric septic shock.

Important Caveats:

• Infants <12 months may be less responsive to dobutamine 2
• If vasopressor support is needed (low SVR, vasodilatory shock), other agents should be used:
  • Norepinephrine for vasodilatory shock
  • Epinephrine at doses >0.3 μg/kg/min produces alpha-adrenergic vasoconstriction 2
  • Dopamine at higher doses (>10 μg/kg/min) produces alpha-adrenergic effects 4

Direct Answer to Your Question

There is no dose of dobutamine that produces a vasopressor effect in a 2-year-old child. The drug's pharmacologic profile remains predominantly beta-adrenergic (inotropic and vasodilatory) across its entire dosing range. If vasopressor support is required, you must select a different agent with alpha-adrenergic activity such as norepinephrine, high-dose epinephrine (>0.3 μg/kg/min), or high-dose dopamine (>10 μg/kg/min) 2, 4.